packageRepotrectinib

repotrectinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Repotrectinib is a protein kinase inhibitor used to treat non-small-cell lung cancer. It is an approved medicine and is authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q123499554 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:repotrectinib
ATC codes:L01EX28
DrugBank:DB16826
PubChem CID:135565923
Wikidata:Q123499554
formula:C18H18FN5O2
molar mass:355.373 g/mol (PubChem CID 135565923)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown